Cargando…
Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic
In March 2020, a 74-year-old man affected by end-stage renal disease and on peritoneal dialysis was referred to an emergency room in Modena, Northern Italy, due to fever and respiratory symptoms. After ruling out COVID-19 infection, a diagnosis of chronic obstructive pulmonary disease exacerbation w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542613/ https://www.ncbi.nlm.nih.gov/pubmed/33028570 http://dx.doi.org/10.1136/bcr-2020-236411 |
_version_ | 1783591583375949824 |
---|---|
author | Mori, Giacomo Alfano, Gaetano Fontana, Francesco Magistroni, Riccardo |
author_facet | Mori, Giacomo Alfano, Gaetano Fontana, Francesco Magistroni, Riccardo |
author_sort | Mori, Giacomo |
collection | PubMed |
description | In March 2020, a 74-year-old man affected by end-stage renal disease and on peritoneal dialysis was referred to an emergency room in Modena, Northern Italy, due to fever and respiratory symptoms. After ruling out COVID-19 infection, a diagnosis of chronic obstructive pulmonary disease exacerbation was confirmed and he was thus transferred to the nephrology division. Physical examination and blood tests revealed a positive fluid balance and insufficient correction of the uraemic syndrome, although peritoneal dialysis prescription was maximised. After discussion with the patient and his family, the staff decided to start hybrid dialysis, consisting of once-weekly in-hospital haemodialysis and home peritoneal dialysis for the remaining days. He was discharged at the end of the antibiotic course, after an internal jugular vein central venous catheter placement and the first haemodialysis session. This strategy allowed improvement of depuration parameters and avoidance of frequent access to the hospital, which is crucial in limiting exposure to SARS-CoV-2 in an endemic setting. |
format | Online Article Text |
id | pubmed-7542613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-75426132020-10-19 Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic Mori, Giacomo Alfano, Gaetano Fontana, Francesco Magistroni, Riccardo BMJ Case Rep Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation) In March 2020, a 74-year-old man affected by end-stage renal disease and on peritoneal dialysis was referred to an emergency room in Modena, Northern Italy, due to fever and respiratory symptoms. After ruling out COVID-19 infection, a diagnosis of chronic obstructive pulmonary disease exacerbation was confirmed and he was thus transferred to the nephrology division. Physical examination and blood tests revealed a positive fluid balance and insufficient correction of the uraemic syndrome, although peritoneal dialysis prescription was maximised. After discussion with the patient and his family, the staff decided to start hybrid dialysis, consisting of once-weekly in-hospital haemodialysis and home peritoneal dialysis for the remaining days. He was discharged at the end of the antibiotic course, after an internal jugular vein central venous catheter placement and the first haemodialysis session. This strategy allowed improvement of depuration parameters and avoidance of frequent access to the hospital, which is crucial in limiting exposure to SARS-CoV-2 in an endemic setting. BMJ Publishing Group 2020-10-07 /pmc/articles/PMC7542613/ /pubmed/33028570 http://dx.doi.org/10.1136/bcr-2020-236411 Text en © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage |
spellingShingle | Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation) Mori, Giacomo Alfano, Gaetano Fontana, Francesco Magistroni, Riccardo Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic |
title | Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic |
title_full | Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic |
title_fullStr | Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic |
title_full_unstemmed | Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic |
title_short | Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic |
title_sort | hybrid dialysis: a promising strategy to reduce hospital access during the sars-cov-2 pandemic |
topic | Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542613/ https://www.ncbi.nlm.nih.gov/pubmed/33028570 http://dx.doi.org/10.1136/bcr-2020-236411 |
work_keys_str_mv | AT morigiacomo hybriddialysisapromisingstrategytoreducehospitalaccessduringthesarscov2pandemic AT alfanogaetano hybriddialysisapromisingstrategytoreducehospitalaccessduringthesarscov2pandemic AT fontanafrancesco hybriddialysisapromisingstrategytoreducehospitalaccessduringthesarscov2pandemic AT magistroniriccardo hybriddialysisapromisingstrategytoreducehospitalaccessduringthesarscov2pandemic |